Profile data is unavailable for this security.
About the company
Shanghai Haohai Biological Technology Co Ltd is a China-based company mainly engaged in the production and sale of biological products, medical hyaluronic acid and intraocular lenses, research and development of bioengineering and pharmaceuticals, and provision of related services. The ophthalmology business has covered cataract treatment, myopia prevention and control, refractive correction, ocular surface medication, and optometry materials such as intraocular lenses and orthokeratology lenses. Medical beauty and wound care products include hyaluronic acid dermal fillers, hyaluronic acid gel for skin and mucosal superficial tissue supplementation. Orthopedic products include orthopedic joint cavity viscoelastic supplements and others. Anti-adhesion and hemostasis products include medical chitosan (for anti-adhesion), medical sodium hyaluronate gel and collagen sponge. The Company mainly conducts its businesses in domestic and foreign markets.
- Revenue in CNY (TTM)2.52bn
- Net income in CNY384.21m
- Incorporated2007
- Employees2.16k
- LocationShanghai Haohai Biological Technology Co Ltd4F, No 2 Building, Alley 139Anshun Road, Changning DistrictSHANGHAI 200336ChinaCHN
- Phone+86 2 152293555
- Fax+86 2 152293558
- Websitehttps://www.3healthcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOB Biotech Group Corp Ltd | 387.48m | 36.43m | 9.03bn | 529.00 | 243.74 | 10.76 | -- | 23.31 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Shinva Medical Instrument Co Ltd | 9.58bn | 508.92m | 9.40bn | 8.14k | 18.52 | 1.20 | -- | 0.982 | 0.837 | 0.837 | 15.78 | 12.91 | 0.6286 | 2.20 | 4.50 | 1,177,051.00 | 3.30 | 4.12 | 6.27 | 8.97 | 24.46 | 25.09 | 5.24 | 5.61 | 0.8863 | -- | 0.124 | 21.15 | 0.0874 | 2.71 | 5.75 | -4.29 | 14.30 | 26.58 |
| Sino Medical Sciences Technology Inc | 504.11m | 29.36m | 9.54bn | 691.00 | 323.32 | 10.54 | -- | 18.92 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 9.66bn | 3.14k | -- | 2.31 | -- | 1.31 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 10.06bn | 2.16k | 28.71 | 1.94 | -- | 3.99 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.33bn | 2.81k | 40.07 | 2.39 | -- | 4.56 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 11.01bn | 2.34k | 143.71 | 5.43 | -- | 14.23 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.11bn | 500.00 | 212.52 | 6.20 | -- | 24.21 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 11.31bn | 1.19k | 965.19 | 2.41 | -- | 6.98 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Holder | Shares | % Held |
|---|---|---|
| Hwabao WP Fund Management Co., Ltd.as of 31 Mar 2025 | 2.45m | 1.26% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 789.46k | 0.41% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 783.65k | 0.40% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 586.46k | 0.30% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 554.80k | 0.29% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 549.68k | 0.28% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 525.96k | 0.27% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 274.48k | 0.14% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 266.42k | 0.14% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 209.98k | 0.11% |
